GlassScriptPhysician profile
Wallace M Green
NPI 1306979059
$59,383.77
in general payments reported to CMS, 2019-2025
51 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.26 · 2020: $32.90 · 2021: $34K · 2022: $20K · 2023: $4,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,606 · Travel and Lodging: $231 · Food and Beverage: $68.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,606.25 |
| Travel and Lodging | $230.56 |
| Food and Beverage | $68.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $45,853.84 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $6,630.43 | 2021 | |
| Allergan, INC. | $1,321.65 | 2021 | |
| Upsher-Smith Laboratories LLC | $464.65 | 2021-2022 | |
| Lilly USA, LLC | $457.68 | 2021-2022 | |
| Harmony Biosciences LLC | $362.77 | 2021-2022 | |
| Ucb, INC. | $341.91 | 2021-2022 | |
| Sk Life Science, INC. | $286.13 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $278.84 | 2021-2022 | |
| Biogen, INC. | $267.27 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $220.50 | 2021-2022 | |
| Neurelis, INC. | $216.73 | 2021-2022 | |
| Amgen INC. | $204.62 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $196.35 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $173.68 | 2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.